Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth R Plimack

Showing results (31-40 of 209) with videos related to

Pageof 21
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Combining epigenetic and cytotoxic therapy in the treatment of solid tumorsElizabeth R Plimack, David J Stewart, Jean-Pierre J Issa
Current Treatment Options in Oncology|February 18, 2017
Checkpoint Inhibitors for the Treatment of Renal Cell CarcinomaPooja Ghatalia, Matthew Zibelman, Daniel M Geynisman, et al.
Discovery Medicine|January 1, 2015
Immune checkpoint blockade as a novel immunotherapeutic strategy for renal cell carcinoma: a review of clinical trialsJ Luke Godwin, Matthew Zibelman, Elizabeth R Plimack, et al.
European Urology|January 15, 2018
Chemoimmunotherapy in Metastatic Urothelial CarcinomaDaniel M Geynisman, Phillip H Abbosh, Elizabeth R Plimack, et al.
Clinical Advances in Hematology & Oncology : H&O|December 14, 2018
Evolving landscape of the treatment of metastatic clear cell renal cell carcinomaPooja Ghatalia, Matthew R Zibelman, Daniel M Geynisman, et al.
Clinical Advances in Hematology & Oncology : H&O|April 11, 2019
Update on perioperative systemic therapy for urothelial carcinomaKeren Rouvinov, Elizabeth R Plimack, Matthew Zibelman, et al.
Cancer|February 26, 2009
Patterns of disease progression in metastatic renal cell carcinoma patients treated with antivascular agents and interferon: impact of therapy on recurrence patterns and outcome measuresElizabeth R Plimack, Nizar Tannir, E Lin, et al.
Therapeutic Advances in Medical Oncology|September 27, 2021
Role of immunotherapy in localized muscle invasive urothelial cancerJasmeet Kaur, Woonyoung Choi, Daniel M Geynisman, et al.
Biologics : Targets & Therapy|December 4, 2012
Potential role of (124)I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancerMarc C Smaldone, David Yt Chen, Jian Q Yu, et al.
Current Opinion in Urology|June 4, 2019
Clinical implications of molecular subtyping in bladder cancerUttam Satyal, Rahmat K Sikder, David McConkey, et al.
Pageof 21

Showing results (31-40 of 209) with videos related to

Sort By:
Pageof 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Combining epigenetic and cytotoxic therapy in the treatment of solid tumorsElizabeth R Plimack, David J Stewart, Jean-Pierre J Issa
Current Treatment Options in Oncology|February 18, 2017
Checkpoint Inhibitors for the Treatment of Renal Cell CarcinomaPooja Ghatalia, Matthew Zibelman, Daniel M Geynisman, et al.
Discovery Medicine|January 1, 2015
Immune checkpoint blockade as a novel immunotherapeutic strategy for renal cell carcinoma: a review of clinical trialsJ Luke Godwin, Matthew Zibelman, Elizabeth R Plimack, et al.
European Urology|January 15, 2018
Chemoimmunotherapy in Metastatic Urothelial CarcinomaDaniel M Geynisman, Phillip H Abbosh, Elizabeth R Plimack, et al.
Clinical Advances in Hematology & Oncology : H&O|December 14, 2018
Evolving landscape of the treatment of metastatic clear cell renal cell carcinomaPooja Ghatalia, Matthew R Zibelman, Daniel M Geynisman, et al.
Clinical Advances in Hematology & Oncology : H&O|April 11, 2019
Update on perioperative systemic therapy for urothelial carcinomaKeren Rouvinov, Elizabeth R Plimack, Matthew Zibelman, et al.
Cancer|February 26, 2009
Patterns of disease progression in metastatic renal cell carcinoma patients treated with antivascular agents and interferon: impact of therapy on recurrence patterns and outcome measuresElizabeth R Plimack, Nizar Tannir, E Lin, et al.
Therapeutic Advances in Medical Oncology|September 27, 2021
Role of immunotherapy in localized muscle invasive urothelial cancerJasmeet Kaur, Woonyoung Choi, Daniel M Geynisman, et al.
Biologics : Targets & Therapy|December 4, 2012
Potential role of (124)I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancerMarc C Smaldone, David Yt Chen, Jian Q Yu, et al.
Current Opinion in Urology|June 4, 2019
Clinical implications of molecular subtyping in bladder cancerUttam Satyal, Rahmat K Sikder, David McConkey, et al.
Pageof 21